Search Ontology:
ChEBI

cenicriviroc

Term ID
CHEBI:149636
Synonyms
  • (5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-(4-{(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl}phenyl)-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide
  • cenicriviroc
  • cenicrivirocum
  • CVC
  • TAK-652
  • TBR 652
  • TBR-652
Definition
A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).
References
  • cas:497223-25-3
  • drugbank:DB11758
  • kegg.drug:D09878
  • pubmed:16251299
  • pubmed:20721836
  • pubmed:25394040
  • pubmed:26247470
  • pubmed:26525792
  • pubmed:27169903
  • pubmed:28940700
  • pubmed:29448843
  • pubmed:29561896
  • pubmed:30088682
  • pubmed:30135687
  • pubmed:30179264
  • pubmed:30239650
  • pubmed:30622370
  • pubmed:31312356
  • pubmed:31629375
  • pubmed:31661521
  • pubmed:31680767
  • pubmed:31731005
  • pubmed:31881392
  • pubmed:31943293
  • pubmed:32013805
  • pubmed:32269742
  • wikipedia.en:Cenicriviroc
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from cenicriviroc
Phenotype where environments contain cenicriviroc
Phenotype modified by environments containing cenicriviroc
Phenotype affecting cenicriviroc
Human Disease Model